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Laminin-1 is a major component and multifunctional glycoprotein of basement membranes that
consists of three different subunits, a1, b1 and g1 chains. It is the earliest synthesized network-forming
protein during embryogenesis and plays an important role in embryonic development, embryonic
implantation and placentation. We have recently shown that IgG anti-laminin-1 antibodies were
signiﬁcantly associated with recurrent ﬁrst-trimester miscarriages and with subsequent pregnancy
outcome. Interestingly, these antibodies were also observed in patients with endometriosis-associated
infertility but not in patients with other causes of infertility, including tubal factors, hormonal and
uterine abnormalities. Laminin-a1, -b1 and -g1 mRNAs have been detected in 90% of endometriotic
lesions and all laminin-a1, -b1 and -g1 chains were localized in the basement membranes of glandular
epithelium in endometriotic peritoneal lesions. Western blot analysis showed that anti-laminin-1
antibodies from those patients reacted with all laminin-1’s chains. ELISA also conﬁrmed that one of the
target epitopes for these antibodies was located in a particular region of the laminin-1 molecule, i.e. the
carboxyl-terminal globular G domain of a1 chain. IgM monoclonal anti-laminin-1 autoantibody, that
we recently established, also recognized the G domain. Anti-laminin-1 antibodies from mice
immunized with “mouse” laminin-1, caused a higher fetal resorption rate with lower embryonic and
placental weights. Thus, anti-laminin-1 antibodies may be important in development of autoimmune-
mediated reproductive failures and the assessment of the antibodies may provide a novel non-invasive
diagnosis of endometriosis.
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INTRODUCTION
Laminin, a multifunctional glycoprotein of basement
membranes, consists of three different subunits, a, b and g
chains (Fig. 1) (Burgeson et al., 1994). Laminins are
involved in diverse biological activities, including the
promotion of cell adhesion, migration, proliferation and
differentiation, as well as the formation of the scaffolding
network in basement membranes (Colognato and
Yurchenco, 2000). These biological processes occur
through signal transduction and cell–matrix interactions
mediated by laminin-speciﬁc receptors and other matrix
components. Many of the responsible sites for these
activities are localized in the carboxyl-terminal globular G
domain of the a chain (Mercurio, 1995; Colognato and
Yurchenco, 2000)
To date, at least 15 different isoforms of laminin have
been identiﬁed and are known to display tissue-speciﬁc
expression during different stages of embryonic develop-
ment (Miner et al., 1997; Libby et al., 2000). Laminin-1,
composed of a1, b1 and g1 chains, is the earliest
synthesized network-forming component during embryo-
genesis and plays an important role in embryonic
development and placentation. These functions have
been conﬁrmed by studies using laminin-a1, -b1o r- g1
chain or b1-integrin knockout mice (Smyth et al., 1999;
Aumailley et al., 2000; Miner et al., 2004).
Laminin-1 from early human embryos increases
type IV collagenase expression and is thought to enhance
trophoblast adhesion to maternal matrix in the peri-
implantation period (Turpeenniemi-Hujanen et al., 1992).
Inblastocystorearlyimplantingmouse embryo, laminin-1
is localized in the inner cell mass and in the trophectoderm
basement membrane. As implantation proceeds, laminin-1
is expressed in chorionic basement membranes and in
Reithert’s membrane near the ectoplacental cone (Klaffky
et al., 2001; Miner et al., 2004). In human ﬁrst-trimester
placenta, laminin-a1 chain is detected in trophoblastic
basement membrane and is in direct contact with
extravillous trophoblastic cells. In second-trimester
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trophoblastic cell columns, laminin-a1 chain is selectively
foundatthesitewherethevillousbasementmembraneisin
contact with proliferating cells in trophoblastic islands or
columns (Korhonen and Virtanen, 2001). Thus, laminin-1
may have an important role in all processes related to
embryogenesis, implantation and placentation.
In the present article, we review the clinical associations
of anti-laminin-1 autoantibodies, mainly based on our
recent studies.
AUTOANTIBODIES TO LAMININS IN ANIMALS
Anti-laminin-1 autoantibodies were ﬁrst detected in the
sera of monkeys with history of reproductive failure, and
their sera caused abnormalities in cultured rat embryos
(Carey and Klein, 1989). It was further demonstrated that
immunization of monkeys with mouse laminin-1 or with
laminin-1 peptides (i.e. YIGSR or RGD) caused
embryotoxicity and infertility/spontaneous abortions
(Weeks et al., 1989; Chambers et al., 1995). Passive
immunization with rabbit anti-laminin-1 antibodies in
pregnant mice induced spontaneous abortions and the
antibodies were also localized in both Reichert’s
membrane and visceral yolk sac endoderm cells of the
embryos (Foidart et al., 1983). We also established an
animal model that produced high titers of anti-laminin-1
antibodies after immunization with mouse laminin-1.
These mice were prone to have a lower successful
pregnancy rate. Moreover, these mice had a higher
incidence of fetal resorption and decreased placental and
embryonic weights (Matalon et al., 2003). Most recently,
we have established a mouse IgM monoclonal antibody
against the G domain of laminin-a1 from mice immunized
with mouse laminin-1 protein as an immunogen
(manuscript in preparation), and we are planning to
establish an anti-laminin-1 animal model.
CLINICAL SIGNIFICANCE OF IGG
ANTI-LAMININ-1 ANTIBODIES
Recurrent Abortions
Our recent clinical study showed that IgG anti-laminin-1
antibodies in blood are signiﬁcantly associated with the
recurrent ﬁrst-trimester miscarriages in humans (Inagaki
etal.,2001).AlloftheseobservationssuggestthatIgGanti-
laminin-1 antibodies may be responsible for reproductive
failure, interfering with an early stage of pregnancy.
A total of 177 recurrent aborters with a history of two or
more consecutive ﬁrst-trimester miscarriages were
enrolled into a study and were tested for the presence of
anti-laminin-1 antibodies, b2-glycoprotein I (b2-GPI)-
dependent anticardiolipin antibodies, lupus anticoagu-
lants, anti-DNA antibodies and antinuclear antibodies
before they conceived again. These recurrent aborters
were then followed up during subsequent pregnancies and
the outcomes were evaluated relative to their blood test
results prior to pregnancy. Fifty-ﬁve (31.1%) women out
of the 177 recurrent aborters were positive for IgG anti-
laminin-1 antibodies. IgG anti-laminin-1 antibody levels
(not IgM antibodies) in recurrent aborters were signiﬁ-
cantly higher than those of healthy pregnant women and
healthy non-pregnant women (P ¼ 0:0043 and 0.0073,
respectively) (Fig. 2). The live birth rate of subsequent
pregnancies of IgG anti-laminin-1 autoantibody-positive
recurrent aborters was signiﬁcantly lower than that of
IgG anti-laminin-1 autoantibodies-negative recurrent
aborters ðP ¼ 0:032Þ (Table I). There were no signiﬁcant
relationships observed between IgG anti-laminin-1
antibodies and other autoantibodies tested (Table II).
This study demonstrated that IgG anti laminin-1
autoantibodies are closely related to recurrent mis-
carriages and subsequent pregnancy outcome of recurrent
aborters. Our ﬁndings suggest that IgG anti-laminin-1
antibodies may have a harmful effect on events at early
stages of pregnancy, such as embryonic implantation,
embryogenesis, placental vascularization and/or placental
nutrient transport.
Infertility Caused by Endometriosis
Our recent clinical study also showed that IgG anti-
laminin-1 antibodies are signiﬁcantly associated
with endometriosis in infertile patients (Inagaki et al.,
2003). Sixty-eight infertile patients who underwent
FIGURE 1 Structure of laminin-1. E3 and E8 designate proteolytic
(elastase) fragmentsof laminin-1.Both a1b1 and a6b1 integrins indicate
the integrin-binding sites of laminin-a1 chain.
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IgG anti-laminin-1 antibodies. Twenty infertile patients
(29%) were positive for anti-laminin-1 antibodies.
Antibody levels in those patients were signiﬁcantly higher
than those in healthy non-pregnant women ðP ¼ 0:0005Þ
(Fig. 3). The presence of the autoantibodies signiﬁcantly
correlated with endometriosis in those patients ðP ¼
0:0096Þ (Table III). Seventeen of 42 infertile patients with
endometriosis (40%) tested positive for anti-laminin-1
antibodies. Other causes of infertility (tubal factor,
hormonal and uterine abnormalities and unexplained)
were not associated with these antibodies. The values of
anti-laminin-1 antibodies were compared between infer-
tile patients with and without endometriosis. Signiﬁcantly
elevated values of the antibodies were observed in 42
infertile patients with endometriosis (the mean
value ¼ 1.1 ^ 1.2U/ml) compared to those without
endometriosis (0.46 ^ 0.33U/ml) ðP ¼ 0:015Þ (Fig. 4).
We demonstrated that infertile patients had signiﬁcantly
higher levels of IgG anti-laminin-1 antibodies. This
ﬁnding suggested that these antibodies are involved not
only in recurrent ﬁrst-trimester miscarriages but also in
infertility in humans. We alsoshowed that these antibodies
were strongly associated with infertility, especially when
caused by endometriosis. Endometriosis is a widely
accepted cause of infertility. A number of studies indicate
that infertile patients with endometriosis frequently have
the elevated levels of autoantibodies speciﬁc for
endometrial, ovarian, nuclear antigens and others (Mathur
et al., 1982; Pillai et al., 1998; Mathur, 2000). Although,
the mechanism(s) of infertility in these disorders is poorly
understood, it has been suggested that an aberrant
immunological mechanism including the production
of autoantibodies might be involved. The presence of
anti-laminin-1 antibodies in infertile patients with
endometriosis and the function of laminin-1 in embryo-
genesis, implantation and placentation suggest that anti-
laminin-1 antibodies may play a role in modulating very
early reproductive processes and be responsible for
endometriosis-associated infertility.
From our data, anti-laminin-1 antibodies in infertile
patients with endometriosis clearly recognized the
G domain of the laminin-a1 chain. The G domain
contains the recognition sites of several integrin receptors,
playing a role in various biological activities (Mercurio,
1995; Colognato and Yurchenco, 2000). It was previously
shown that the direct inhibition of laminin-1 binding to
integrin receptors and to other basement membrane
components by anti-laminin-1 antibodies, impaired the
formation of normal basement membranes and epithelial
morphogenesis (Kadoya et al., 1995). Therefore, it is
possible that these antibodies may also directly interfere
FIGURE 2 Levels of IgG or IgM anti-laminin-1 antibodies in recurrent spontaneous aborters. Anti-laminin-1 antibodies were detected in ELISA using
a laminin-1-coated plate. The dotted line shows 1U/ml (1U/ml ¼ OD, the mean þ 3 SD of healthy non-pregnant women), as a cut off value of the
antibodies. Solid lines show the mean value. (Inagaki et al., 2001).
TABLE I Relationship between the prevalence of anti-laminin-1 autoantibodies and subsequent pregnancy outcome in recurrent spontaneous aborters
Anti-laminin-1 Ab (IgG) Anti-laminin-1 Ab (IgM)
Characteristics Positive (N ¼ 38) Negative (N ¼ 85) P value Positive (N ¼ 40) Negative (N ¼ 83) P value
Age 30.0 ^ 3.9 30.0 ^ 3.3 NS 29.3 ^ 3.0 30.8 ^ 3.7 NS
Number of previous pregnancy losses 2.8 ^ 1.5 2.8 ^ 1.3 NS 3.0 ^ 1.6 2.7 ^ 1.2 NS
Outcome of subsequent pregnancy
Live births 19 59 28 50
Percent live births 50.0 69.4 0.032 70.0 61.0 NS
*P, Fisher’s exact test. (Inagaki et al., 2001).
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reproductive stages and be involved in the development
of endometriosis. In light of these ﬁndings, anti-laminin-1
antibodies might be clinically important in development
of autoimmune-mediated reproductive failure and the
antibody assessment may provide a novel non-invasive
diagnosis of endometriosis.
LAMININ-1 EXPRESSION
ELISA showed speciﬁc autoantibody reactivity to a
particular region of the laminin-1 molecule, i.e. a1 chain
G domain. Laminin-a1, -b1 and -g1 mRNAs were also
detected in 90% of endometriotic lesions. Immunohisto-
chemical study with speciﬁc monoclonal antibodies
demonstrated that laminin-a1, -b1 and -g1 chains are
present in the basement membranes of glandular
epithelium in endometriotic peritoneal lesions. Laminin-
a1 chain was detected only in the basement membranes of
glandular epithelium, whereas laminin-b1 and -g1 chains
were strongly expressed in the basement membranes
of vascular endothelium and in the extracellular matrix of
peristromal smooth muscle cells, in addition to
the basement membranes of glandular epithelium (manu-
script in preparation).
SPECIFICITY OF ANTI-LAMININ-1 ANTIBODIES
UsingWesternblotanalysis,weshowedthatanti-laminin-1
antibodies from those patients reacted with all laminin-1’s
chains,i.e.-a1,-b1and-g1(Fig.5).ELISAalsoconﬁrmed
that a target epitope for the antibodies is present in a
particular region of the laminin-1 molecule, i.e. carboxyl-
terminalglobularGdomainofa1chain(Fig.6).Ithasbeen
FIGURE 3 IgG values of anti-laminin-1 antibodies in 68 infertile
patients who underwent laparoscopy or laparotomy. Anti-laminin-1
antibodies were detected in ELISA using a laminin-1-coated plate. The
dotted line shows 1U/ml (1U/ml ¼ OD, the mean þ 3 SD of healthy
non-pregnant women), as a cut off value of the antibodies. Solid lines
show the mean value. (Inagaki et al., 2003).
TABLE III Association between IgG anti-laminin-1 autoantibodies and
possible causes of infertility in 68 infertile patients who underwent
laparoscopy or laparotomy
Anti-laminin-1 Abs
Possible cause of infertility
Positive
(n=20)
Negative
(n=48) P value
Endometriosis
þ 17 25 0.0096
2 32 3
Tubal factor
þ 51 7N S
2 15 31
Hormonal abnormality
þ 51 1N S
2 15 37
Uterine anomaly
þ 02 N S
2 20 46
Unexplained
þ 11 0N S
2 19 38
P, Fisher’s exact test; NS, not signiﬁcant. (Inagaki et al., 2003).
TABLE II Relationship in the prevalence of anti-laminin-1 autoantibodies, b2-GPI-dependent aCL, LA, aDNA and ANA in recurrent aborters
Anti-laminin-1
Abs (IgG)
aCL LAC anti-DNA Abs ANA
% Positive Negative P* % Positive Negative P % Positive Negative P % Positive Negative P
Positive 31.1 1 54 NS 31.1 11 44 NS 31.1 8 47 NS 31.1 12 43 NS
Negative 68.9 3 119 68.9 16 106 68.9 18 104 68.9 17 105
*P, Fisher’s exact test. (Inagaki et al., 2001).
FIGURE 4 Comparison of IgG values of anti-laminin-1 antibodies
between infertile patients with and without endometriosis. The dotted and
solid lines show the cut off and meanvalues of the antibodies, respectively.
(Inagaki et al.,2 0 0 3 ) .
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activities including promotion of heparin binding, cell
attachment and neurite outgrowth are localized in the
Gdomain.Ourmostinterestiswhethersuchanti-laminin-1
antibodies that are associated with fetal loss and/or
endometriosis-associated infertility may or may not
prevent the cell–cell interaction and impair the formation
of normal basement membranes and disrupt early
reproductive stages, i.e. whether the antibodies are
“pathogenic” or “protective”, or just epiphenomenon.
Aspreviouslydescribed,anti-laminin-1antibodiesinduced
by active immunization (with mouse laminin-1 as an
autoantigen) affected fetal development in the immunized
mice. Furthermore, IgM monoclonal autoantibodies to
laminin-1alsorecognizedtheGdomain.Anyway,laminins
seem to be highly immunogenic and antibodies may be
polyclonally induced to a variety of epitopic structures on
the protein molecules.
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